These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2056609)
21. Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup. Adolfsson J; Steineck G; Hedlund PO J Urol; 1999 Feb; 161(2):505-8. PubMed ID: 9915436 [TBL] [Abstract][Full Text] [Related]
22. How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden. Andrén O; Fall K; Franzén L; Andersson SO; Johansson JE; Rubin MA J Urol; 2006 Apr; 175(4):1337-40. PubMed ID: 16515993 [TBL] [Abstract][Full Text] [Related]
23. Deferred treatment of low grade stage T3 prostate cancer without distant metastases. Adolfsson J J Urol; 1993 Feb; 149(2):326-8; discussion 328-9. PubMed ID: 8426412 [TBL] [Abstract][Full Text] [Related]
24. The Risk of Distant Metastases and Cancer Specific Survival in Men with Serum Prostate Specific Antigen Values above 100 ng/ml. Stattin K; Sandin F; Bratt O; Lambe M J Urol; 2015 Dec; 194(6):1594-600. PubMed ID: 26192253 [TBL] [Abstract][Full Text] [Related]
25. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. Johansson JE; Holmberg L; Johansson S; Bergström R; Adami HO JAMA; 1997 Feb; 277(6):467-71. PubMed ID: 9020270 [TBL] [Abstract][Full Text] [Related]
26. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
27. Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases. Osunkoya AO; Nielsen ME; Epstein JI Am J Surg Pathol; 2008 Mar; 32(3):468-72. PubMed ID: 18300802 [TBL] [Abstract][Full Text] [Related]
29. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. Stattin P; Holmberg E; Bratt O; Adolfsson J; Johansson JE; Hugosson J; J Urol; 2008 Dec; 180(6):2423-9; discussion 2429-30. PubMed ID: 18930283 [TBL] [Abstract][Full Text] [Related]
30. Outcome based staging for clinically localized adenocarcinoma of the prostate. D'Amico AV; Whittington R; Schultz D; Malkowicz SB; Tomaszewski JE; Wein A J Urol; 1997 Oct; 158(4):1422-6. PubMed ID: 9302135 [TBL] [Abstract][Full Text] [Related]
31. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. Epstein JI; Paull G; Eggleston JC; Walsh PC J Urol; 1986 Oct; 136(4):837-9. PubMed ID: 3761442 [TBL] [Abstract][Full Text] [Related]
32. Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. Steinberg GD; Epstein JI; Piantadosi S; Walsh PC J Urol; 1990 Dec; 144(6):1425-32. PubMed ID: 1700157 [TBL] [Abstract][Full Text] [Related]
33. Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging. Muralidhar V; Dinh KT; Mahal BA; Ziehr DR; Chen YW; Viswanathan VB; Nezolosky MD; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Trinh QD; Nguyen PL Urol Oncol; 2015 Jul; 33(7):330.e19-25. PubMed ID: 25990612 [TBL] [Abstract][Full Text] [Related]